Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma

NCT00177554 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00177554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00177554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma
Lead sponsor
University of Pittsburgh
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2003
Completion date
May 31, 2007
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-hodgkin lymphoma